Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus

G M Glenn, L N Daniel, P Choyke, W M Linehan, E Oldfield, M B Gorin, S Hosoe, F Latif, G Weiss, M Walther, G M Glenn, L N Daniel, P Choyke, W M Linehan, E Oldfield, M B Gorin, S Hosoe, F Latif, G Weiss, M Walther

Abstract

As part of an attempt to locate the von Hippel-Lindau locus (VHL) on chromosome 3, we evaluated 41 families with von Hippel-Lindau disease from the United States and Canada. One large family was identified whose disease phenotype was distinct from typical VHL. The most common disease manifestation was pheochromocytoma occurring in 57% (27/47) of affected family members. Few (4/47) affected family members had symptomatic spinal or cerebellar hemangioblastomas; no affected family member had renal cell carcinoma (0/47) or pancreatic cysts (0/24). Previously, genetic analysis demonstrated that the disease manifestations in this family were linked to RAF1 and D3S18, markers shown to be linked to typical VHL. These results suggest that there are mutant alleles at the VHL locus associated with distinct tissue specificities.

References

    1. Am J Hum Genet. 1988 Nov;43(5):638-44
    1. Genomics. 1990 Oct;8(2):313-7
    1. Am J Med. 1953 Mar;14(3):318-27
    1. N Engl J Med. 1990 Mar 29;322(13):904-8
    1. J Natl Cancer Inst. 1989 Jul 19;81(14):1097-101
    1. Genomics. 1990 Mar;6(3):565-7
    1. Trans Am Ophthalmol Soc. 1970;68:367-424
    1. Q J Med. 1990 Nov;77(283):1151-63
    1. Ann Ophthalmol. 1977 Feb;9(2):177
    1. Radiology. 1990 Mar;174(3 Pt 1):815-20
    1. Medicine (Baltimore). 1979 May;58(3):209-18
    1. Hum Genet. 1989 Nov;83(4):353-8
    1. Medicine (Baltimore). 1989 Jan;68(1):1-29
    1. Am J Med. 1964 Apr;36:595-617
    1. Angiology. 1971 Mar;22(3):141-6
    1. Arch Intern Med. 1976 Jul;136(7):769-77
    1. CMAJ. 1986 Jan 15;134(2):133-8, 146
    1. J Comput Assist Tomogr. 1989 Sep-Oct;13(5):743-55
    1. Can J Ophthalmol. 1976 Oct;11(4):282-9
    1. Genomics. 1990 Dec;8(4):634-40

Source: PubMed

3
Sottoscrivi